z-logo
open-access-imgOpen Access
Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed
Author(s) -
Nasha Zhang,
Li Kong,
Fang Shi,
Jing Wang,
Haiyong Wang,
Ming Yang,
Jinming Yu,
Hui Zhu
Publication year - 2017
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.23291
Subject(s) - carcinoembryonic antigen , pemetrexed , bevacizumab , medicine , oncology , lung cancer , cancer research , cancer , chemotherapy , cisplatin

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom